Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT01270334
Other study ID # cytoph
Secondary ID
Status Not yet recruiting
Phase N/A
First received January 4, 2011
Last updated January 4, 2011
Start date February 2011

Study information

Verified date January 2011
Source HaEmek Medical Center, Israel
Contact shira baram, dr
Phone 972-4-6494035
Email shira_ba@clalit.org.il
Is FDA regulated No
Health authority Israel- Health ministery, Israel:
Study type Observational

Clinical Trial Summary

vaginal PH has an effect on the effectiveness of treatment with misoprostol given vaginally for missed abortions in the first trimester


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 400
Est. completion date
Est. primary completion date
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 50 Years
Eligibility Inclusion

- missed abortion under 8 weeks by sac diameter over 18 years old informed concent given

Exclusion Criteria:

- missed abortion over 8 weeks hypersensitivity for PG vaginal bleeding suspected EUP IUD heart disease, HTN, cerebral vascular disease, epilepsy intrauterine infection clooting disorder under 18

Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Other:
PH meassurment
meassuring ph USING PROBE

Locations

Country Name City State
Israel Haemel Medical Center Afula

Sponsors (1)

Lead Sponsor Collaborator
HaEmek Medical Center, Israel

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary treatment failure- need for D&C 2 weeks No
Secondary side effects, need foe analgetics, time for compliting abortion 2 weeks No